AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24418726
Drug: Inhaled CO2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled CO2 (1%-2%) during exercise
Trial: 22851561
Drug: Standard (conventional)
RxNorm normalized name: Stangard
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard (conventional) fractionated radiotherapy (STRT) followed by chemotherapy
Trial: 22851561
Drug: Hyperfractionated radiotherapy
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hyperfractionated radiotherapy (HFRT) followed by chemotherapy
Trial: 22851561
Drug: Both treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both treatment arms (HFRT and STRT)
Trial: 19220307
Drug: Sumatriptan/Naproxen Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan/Naproxen Sodium 85/500 mg (S/NS)
Trial: 15683159
Drug: Combined hepatitis
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined hepatitis A and hepatitis B vaccine
Trial: 15683159
Drug: Monovalent hepatitis
RxNorm normalized name: hepatitis nosodes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monovalent hepatitis A and hepatitis B vaccine
Trial: 2126437
Drug: Pravastatin 5
RxNorm normalized name: pravastatin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin 5 mg
Trial: 8726243
Drug: Pravastatin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (all doses)
Trial: 7211425
Drug: Pimozide (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pimozide (1 to 2.6 mg per day)
Trial: 23893418
Drug: Placebo (saline
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (saline solution) injection
Trial: 19552748
Drug: Verapamil (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil (80 mg three times daily for 6 days)
Trial: 16735920
Drug: Hypertonic Dead
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic Dead Sea salt (DSS) solution
Trial: 11370224
Drug: Quadruple therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple therapy (PPI + three antibiotics)
Trial: 11370224
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (PPI + two antibiotics)
Trial: 3801953
Drug: Combination antiemetic
RxNorm normalized name: ANTIEMETICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination antiemetic therapy
Trial: 25046948
Drug: Wuling Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wuling Capsule (WC), 0.33 g each pill, 3 pills per day, three times per day
Trial: 25046948
Drug: Placebo, 3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, 3 pills per day, three times per day
Trial: 19912735
Drug: Wuling Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wuling Capsule (WC)
Trial: 17880761
Drug: IL-15 treatment
RxNorm normalized name: Humax-IL 15
DrugBank: Ordesekimab (DB16649)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IL-15 treatment in vitro
Trial: 11837554
Drug: BMS‐284756 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS‐284756 (400 mg) after a high-fat meal
Trial: 11837554
Drug: BMS‐284756 (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BMS‐284756 (400 mg) in a fasted state
Trial: 7587260
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of preoperative, intraoperative, and postoperative variables (including Parsonnet score, APACHE II and III scores)
Trial: 1775733
Drug: Pizotifen 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pizotifen 0.5 mg
Trial: 1775733
Drug: Metergoline 6
RxNorm normalized name: Metergoline
DrugBank: Metergoline (DB13520)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metergoline 6 mg
Trial: 760752
Drug: Methysergide 2
RxNorm normalized name: methysergide 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methysergide 2 mg
Trial: 6133757
Drug: 0.6 mg
RxNorm normalized name: thymol 0.6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg LH-RH daily for 4 weeks (placebo-controlled)
Trial: 6133757
Drug: 1.2 mg
RxNorm normalized name: RNA 1.2 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 mg LH-RH daily for 4 weeks (open study)
Trial: 28233071
Drug: Active laser
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active laser group (ALG) received pulsed high-intensity laser therapy (HILT) three times per week for 6 weeks, along with 10 mg cetirizine tablets twice daily and 10 mg at bedtime.
Trial: 17577323
Drug: Lactobacillus brevis-containing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus brevis-containing lozenges
Trial: 15631350
Drug: Non-operative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-operative treatment (n = 31)
Trial: 15631350
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (n = 33)
Trial: 11294772
Drug: Ghrelin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ghrelin (10 microg/kg, intravenous bolus)
Trial: 7760586
Drug: Flunarizine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flunarizine (5 mg twice-daily for 1 month, then 5 mg once-daily for 2 months)
Trial: 7760586
Drug: Placebo (matching
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (matching capsule)
Trial: 23669294
Drug: Zoledronic acid
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Zoledronic acid (5 mg intravenous infusion per year)
Trial: 16406221
Drug: Oxytocin infusion
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxytocin infusion (starting from 2 mIU/min, increased every 30 min up to 40 mIU/min)
Trial: 12553389
Drug: Oral ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ketamine 8 mg kg(‐1)
Trial: 12553389
Drug: Oral ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ketamine 4 mg kg(‐1)
Trial: 12553389
Drug: Oral ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral ketamine 6 mg kg(‐1)
Trial: 1739573
Drug: Diclofenac sodium
RxNorm normalized name: Diclofenac Sodium
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac sodium suppositories 150‐200 mg day‐1
Trial: 24740822
Drug: Intraarticular sprifermin
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraarticular sprifermin (10 μg, 30 μg, 100 μg)
Trial: 20586935
Drug: sequential therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sequential therapy of lamivudine‐interferon‐alpha2b
Trial: 9672727
Drug: Modified Cognitive-Behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified Cognitive-Behavioural Therapy (MCBT)
Trial: 9672727
Drug: Conjoint Family
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjoint Family Therapy (FT)
Trial: 9672727
Drug: Eclectic Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Eclectic Therapy (ET)
Trial: 8608658
Drug: No ACE
RxNorm normalized name: Amino Acetic Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No ACE inhibitor
Trial: 27825957
Drug: 25 ml
RxNorm normalized name: ethanol 6.025 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 ml water
Trial: 23564595
Drug: 74 g
RxNorm normalized name: WATER 99.9974 g in 100 L ORAL LIQUID [37.4]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 74 g Corinthian raisins
Trial: 23564595
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g glucose (reference food)
Trial: 21775755
Drug: α-lipoic acid
RxNorm normalized name: α-lipoic acid
DrugBank: Lipoic acid (DB00166)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: α-lipoic acid (ALA) 600 mg once daily
Trial: 19857148
Drug: Mould-active agent
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mould-active agent for high-risk allogeneic HSCT recipients
Trial: 17030231
Drug: Salmeterol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol (50 microg) with fluticasone propionate (100 microg) administered twice daily for 12 weeks
Trial: 17030231
Drug: Montelukast administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Montelukast administered daily for 12 weeks
Trial: 6354929
Drug: Captopril 50
RxNorm normalized name: captopril 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 50 mg t.i.d.
Trial: 10828632
Drug: Petrolatum-based formulation
RxNorm normalized name: PETROLATUM BASE
DrugBank: Petrolatum (DB11058)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Petrolatum-based formulation delivered via a novel diaper
Trial: 10828633
Drug: Control diaper
RxNorm normalized name: Vanicream Diaper Rash
DrugBank: Dimethicone (DB11074)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control diaper (identical to test product without petrolatum formulation)
Trial: 2876485
Drug: Clonazepam (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam (1 mg h.s.)
Trial: 2876485
Drug: Temazepam (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temazepam (30 mg h.s.)
Trial: 31828166
Drug: Adjusted insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Adjusted insulin (daily insulin needed on the day after hemodialysis)
Trial: 31828166
Drug: Nonadjusted insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nonadjusted insulin (25% decrease in daily insulin needed on the day after hemodialysis)
Trial: 26437376
Drug: ITX5061 (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ITX5061 (150 mg immediately before and after transplant and daily for 1 week)
Trial: 26437376
Drug: Control (first
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (first 13 patients did not receive drug)
Trial: 19488642
Drug: Combination hydralazine/nitrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination hydralazine/nitrate
Trial: 17250745
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg of physostigmine
Trial: 15774291
Drug: Glutamine granules
RxNorm normalized name: Glutamine
DrugBank: L-Glutamine (DB00130)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Glutamine granules (0.5 g/kg per day for 14 days)
Trial: 12081987
Drug: Omapatrilat 80
RxNorm normalized name: OMAPATRILAT
DrugBank: Omapatrilat (DB00886)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omapatrilat 80 mg daily
Trial: 14517164
Drug: Enalapril 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 40 mg daily
Trial: 7656295
Drug: Brushing twice
RxNorm normalized name: Tice BCG
DrugBank: Bacillus calmette-guerin substrain tice live antigen (DB10343)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brushing twice a day
Trial: 2697708
Drug: No systemic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No systemic therapy (group 4, n = 32)
Trial: 180196
Drug: Topical treatment
RxNorm normalized name: Hongo Killer Treatment Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical treatment with 3% adenine arabinoside
Trial: 180196
Drug: Topical treatment
RxNorm normalized name: Hongo Killer Treatment Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical treatment with placebo ointment
Trial: 31691472
Drug: MYL-1501D (weeks
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MYL-1501D (weeks 0-12), reference insulin glargine (weeks 12-24), MYL-1501D (weeks 24-36)
Trial: 31691472
Drug: Reference insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reference insulin glargine for 36 weeks
Trial: 31691472
Drug: MYL-1501D and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MYL-1501D and reference insulin glargine
Trial: 30084719
Drug: Maternal ADHD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal ADHD treatment (group psychotherapy and open methylphenidate medication)
Trial: 30084719
Drug: Control treatment
RxNorm normalized name: SALICYLIC ACID 190 mg in 1 mL TOPICAL LIQUID [Derma E Acne Blemish Control Treatment Serum]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control treatment (individual counselling without psycho‐ or pharmacotherapy)
Trial: 14872173
Drug: F3212 (dengue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F3212 (dengue vaccine containing 3, 2, 1 and 2 log10 of the 50% cell culture infective dose of serotypes 1, 2, 3 and 4)
Trial: 14872173
Drug: F3313 (dengue
FDA approved: no
EMA approved: no
PMDA approved: no
Description: F3313 (dengue vaccine containing 3, 3, 1 and 3 log10 of the 50% cell culture infective dose of serotypes 1, 2, 3 and 4)
Trial: 14872173
Drug: Purified Vero
RxNorm normalized name: RAYON,PURIFIED
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Purified Vero cell rabies vaccine (control group)
Trial: 3294714
Drug: Emepronium bromide
RxNorm normalized name: emepronium bromide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Emepronium bromide (Cetiprin) 25 mg t.i.d. administered intramuscularly
Trial: 11759177
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered intramuscularly
Trial: 29028848
Drug: Synthetic resorbable
RxNorm normalized name: Synthetic camphor
DrugBank: Synthetic camphor (DB14156)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Synthetic resorbable membrane (PLA membrane); test group, 30 implants
Trial: 29028848
Drug: Collagen resorbable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Collagen resorbable membrane; control group, 30 implants
Trial: 28237253
Drug: Injection of
RxNorm normalized name: purified protein derivative of tuberculin Injectable Solution [Aplisol]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Injection of plasma rich in growth factors (PRGF)
Trial: 23715891
Drug: Tranexamic acid
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tranexamic acid (TXA) 15 mg/kg body weight intravenously before skin incision
Trial: 23715891
Drug: Placebo (0.9%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (0.9% Sodium chloride solution) intravenously before skin incision
Trial: 20832243
Drug: Topical honey
RxNorm normalized name: Honey
DrugBank: Honey (DB14242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical honey
Trial: 18594749
Drug: Thermal water
RxNorm normalized name: thermal water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thermal water nasal spray 4 times/day for 4 weeks
Trial: 18594749
Drug: Saline nasal
RxNorm normalized name: Ayr Saline Nasal
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline nasal spray 4 times/day for 4 weeks
Trial: 18594749
Drug: Thermal water
RxNorm normalized name: thermal water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thermal water nasal spray
Trial: 18594749
Drug: Saline nasal
RxNorm normalized name: Ayr Saline Nasal
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline nasal spray
Trial: 1990896
Drug: Low-dose clonidine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose clonidine (7-cm2 transdermal patch + oral 3 micrograms.kg-1)
Trial: 1990896
Drug: High-dose clonidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose clonidine (10.5-cm2 transdermal patch + oral 4.5 micrograms.kg-1 at bedtime and 6.0 micrograms.kg-1 on morning of surgery)
Trial: 1990896
Drug: Placebo (occlusive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (occlusive patch without active ingredient + oral placebo tablets)
Trial: 6129979
Drug: UK‐33,274 (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UK‐33,274 (average dose 4.5 mg)
Trial: 6129979
Drug: Prazosin (average
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prazosin (average dose 2.4 mg)
Trial: 28624988
Drug: Oral mifepristone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral mifepristone (400 mg)
Trial: 28624988
Drug: Balloon catheter
RxNorm normalized name: Paclitaxel coated angioplasty balloon catheter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balloon catheter (Foley's catheter 16 Fr; bulb filled with 30 ml normal saline)
Trial: 17683402
Drug: Ketamine 0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.25 mg.kg(-1)
Trial: 16361558
Drug: Primary systemic
RxNorm normalized name: Sodium primary phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primary systemic therapy (arm C)
Trial: 15997936
Drug: EDTA-T gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EDTA-T gel (5%, 10%, 15%, 20%, 24%) applied for 1, 2, or 3 minutes using passive and active methods
Trial: 29160391
Drug: Negative control
RxNorm normalized name: GLYCERIN NEGATIVE CONTROL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative control (saline solution)
Trial: 10440417
Drug: 375 mg
RxNorm normalized name: niacin 375 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 375 mg loading dose of clopidogrel on day 1, followed by 75 mg daily from day 2 to day 10.
Trial: 10440417
Drug: Loading doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loading doses of 75 mg, 150 mg, 225 mg, or 300 mg of clopidogrel on day 1, followed by 75 mg daily from day 2 to day 5.
Trial: 6640241
Drug: Metronidazole 500
RxNorm normalized name: metronidazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 500 mg i.v.
Trial: 6640241
Drug: Metronidazole 500
RxNorm normalized name: metronidazole 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole 500 mg i.v. + Cefuroxime 1.5 g i.v.
Trial: 30883781
Drug: Silver fluoride
RxNorm normalized name: SILVER FLUORIDE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silver fluoride (AgF) treatment
Trial: 20733558
Drug: Trabeculectomy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trabeculectomy with ologen implant
Trial: 18052557
Drug: Vitamin B(6)
RxNorm normalized name: VITAMIN B
DrugBank: Inositol (DB13178)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin B(6) (daily dose of 1200 mg)
Trial: 15722001
Drug: Cognitive Behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behaviour Therapy (CBT) intervention from trained nurses in the community
Trial: 15722001
Drug: Cognitive Behaviour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behaviour Therapy (CBT) intervention
Trial: 12131685
Drug: Selective bowel
RxNorm normalized name: ascorbic acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Selective bowel decontamination (SBD) regimen consisting of gentamicin 80 mg + polymyxin E 100 mg + nystatin 2 million units
Trial: 30616014
Drug: 5-day course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-day course of oral antibiotics (colistin sulphate 2 × 106 IU 4×/day; neomycin sulphate 500 mg 4×/day) followed by frozen faecal microbiota transplantation (FMT) from unrelated healthy donors
Trial: 30513812
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D tablets (1000 IU/day)
Trial: 30513812
Drug: Vitamin D-fortified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D-fortified milk (40 IU/200 mL)
Trial: 24903663
Drug: Maternal RSV
RxNorm normalized name: RSV-IGIV
DrugBank: Respigam (DB17765)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal RSV antibody titers in the third trimester and at birth
Trial: 24903663
Drug: Higher cord
RxNorm normalized name: Bos taurus umbilical cord preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher cord blood RSV antibody titers
Trial: 24903663
Drug: Maternal antibody
RxNorm normalized name: Maternal antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maternal antibody half-life
Trial: 24903663
Drug: Ratio of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ratio of infant cord blood to maternal serum RSV antibody titers
Trial: 17534541
Drug: Sitz bath
RxNorm normalized name: SITZ BATH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sitz bath (twice daily) along with analgesics and fiber supplement
Trial: 17534541
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (analgesics and fiber supplement only)
Trial: 8306409
Drug: OK-432 i.p.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OK-432 i.p. for 7 days, intradermal injection for 1 year at 2-week intervals
Trial: 3394332
Drug: Deverol drgs.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deverol drgs. (50 mg)
Trial: 3394332
Drug: Osiren drgs.
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Osiren drgs. (100 mg)
Trial: 29888570
Drug: Acupuncture plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture plus intra-articular injection of sodium hyaluronate (2 mL once a week for 5 weeks)
Trial: 29888570
Drug: Simple medication
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simple medication (intra-articular injection of sodium hyaluronate 2 mL once a week for 5 weeks)
Trial: 29083275
Drug: OADs and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OADs and insulin
Trial: 23244028
Drug: Telephone-delivered cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone-delivered cognitive-behavioral therapy (T-CBT)